Skip to main content
Clinical Trials/ISRCTN50312145
ISRCTN50312145
Completed
未知

A multicentre Prospective Randomised Controlled Trial of Thrombosis Prophylaxis with Warfarin in Cancer Patients with Central Venous Catheters (CVCs)

Cancer Research UK (UK)0 sites1,400 target enrollmentApril 7, 2004
ConditionsCancer

Overview

Phase
未知
Intervention
Not specified
Conditions
Cancer
Sponsor
Cancer Research UK (UK)
Enrollment
1400
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Registry
who.int
Start Date
April 7, 2004
End Date
October 15, 2000
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Histologically or clinically confirmed diagnosis of cancer
  • 2\. Patients who are due to have a CVC inserted for administration of chemotherapy
  • 3\. Aged at least 16
  • 4\. Adequate haematological, hepatic and renal function
  • 5\. Able to provide written informed consent

Exclusion Criteria

  • 1\. Patients with contraindication to warfarin (including congenital bleeding disorders, anatomic lesions that bleed e.g. duodenal ulcers and profound concomitant therapy interaction)
  • 2\. Patients currently on warfarin
  • 3\. Patients who have previously been entered into WARP
  • 4\. Use of CVC for additional purposes with the exception of antibiotic therapy and blood products
  • 5\. Pregnant or lactating women
  • 6\. Fertile persons, not taking adequate contraceptive measures

Outcomes

Primary Outcomes

Not specified

Similar Trials